Navigation Links
Baxter Releases Ninth Annual Sustainability Report
Date:6/19/2008

Announces Companywide Sustainability Goals to Drive Long-Term Progress

DEERFIELD, Ill., June 19 /PRNewswire-FirstCall/ -- Baxter International Inc. (NYSE: BAX) today released its 2007 Sustainability Report -- Our Priorities. Our Progress., which highlights the company's 2007 social, economic and environmental performance. The report features the establishment of performance goals to support the company's sustainability priorities announced in 2007. The goals further demonstrate Baxter's commitment to integrating sustainability more deeply in the company, encouraging continuous improvement and helping stakeholders assess progress.

"As a healthcare company dedicated to saving and sustaining lives, the critical nature of our work naturally aligns with sustainability," said Robert L. Parkinson, Jr., Baxter's chairman and chief executive officer. "The establishment of Baxter's sustainability goals will help us monitor the progress we make in each priority area in working toward a more sustainable future."

The sustainability goals focus company efforts in the priority areas of Baxter employees, Baxter operations and products, and the world in which the company operates. They reflect issues of key concern to Baxter and its stakeholders and areas where the company is uniquely positioned to have a positive impact. Examples include:

-- Reducing greenhouse gas emissions 45 percent indexed to revenue from 2005 baseline to drive reductions in the company's carbon footprint by 2015;

-- Reducing total waste generation 30 percent indexed to revenue from 2005 baseline to drive reductions in the company's natural resource use by 2015; and

-- Increasing R&D investment to improve access to healthcare for developing and
'/>"/>

SOURCE Baxter International Inc.
Copyright©2008 PR Newswire.
All rights reserved

Page: 1 2 3

Related medicine news :

1. John D. Baxter, M.D. Joins Bionovos Board of Directors
2. FDA Finds Contaminant in Baxters Recalled Heparin Products
3. Baxter Recalls Rest of Heparin Products
4. Nektar Announces Agreement With Baxter to Develop New PEGylated Therapeutics for Hemophilia
5. Baxter Reports Strong Third Quarter Sales and Earnings
6. Baxter International Third Quarter 2007 Financial Results Conference Call
7. Partnership Releases 20th Annual Survey of Parental Attitudes Toward Drug Use
8. United Cerebral Palsy Releases Annual State Medicaid Rankings
9. Trust for Americas Health Releases Report on Connection between Womens Health and Stalled Infant Mortality Rates
10. Fitness Anywhere, Maker of the TRX Suspension Trainer(TM), Releases Two New Specialized Training Programs
11. Edge Health Solutions Releases edgeDMS(TM) 2.0 and edgeMD 2.0(TM), Revolutionary All-in-One Practice Management Software with FDA-Approved Advanced Visualization

Post Your Comments:
*Name:
*Comment:
*Email:
(Date:12/1/2009)..., , RED BANK, N.J., Dec. 1 /PRNewswire/ ...rs know breastfeeding is ideal for their babies an...o decide what works best for them and their famili...inr.mediaseed.tv/IFC_37156/ ,, The survey of m...d that most mothers (83%) made their infant feedin...
(Date:12/1/2009)...iscovery could aid in development of simple screen...1 (HealthDay News) -- In a finding that could lead... U.S. researchers have identified immune system ma...ple at high risk for lung cancer. , The researc...mples from 137 people with non-small cell lung ca...
(Date:12/1/2009)...DC urges H1N1 vaccination because pandemic,s cours.... 1 (HealthDay News) -- A U.S. health official sai... be on the wane nationally, but many experts agree...r. , The flu is now widespread in 32 states -- ... Frieden, director of the U.S. Centers for Disease...
(Date:12/1/2009)... Ever thought you could qu...! Kevin Arthur Smith,s groundbreaking new system f...y, permanent. In just twenty eight days your cravi... , (PRWEB) December 1, 20...uring her eight-year addiction to nicotine, smokin...
(Date:12/1/2009)..., , ,, NEW YORK, Dec. 1 /P...and a global leader in the development and deliver...for the medical, scientific and academic markets, ...versal Search, our first-to-market cross-platform ...sychology lexicon, based on the American Psycholog...
Breaking Medicine News(10 mins):Health News:VIDEO from Medialink and HealthyWomen: Breast, Bottle or Both? 2Health News:Gene 'Signature' May Point to Lung Cancer 2Health News:Swine Flu Waning, But Could Return 2Health News:Swine Flu Waning, But Could Return 3Health News:Former Cigarette Dealer Sells Business in Order to Fund Quit Smoking Book 2Health News:Former Cigarette Dealer Sells Business in Order to Fund Quit Smoking Book 3Health News:Ovid Highlights the Latest Productivity Workflow Enhancements to Ovid Universal Search(TM) and its New Psychology Lexicon at London's Online Information 2009 Conference 2Health News:Ovid Highlights the Latest Productivity Workflow Enhancements to Ovid Universal Search(TM) and its New Psychology Lexicon at London's Online Information 2009 Conference 3
...ill, arsenic also can prolong the lives of patient...aturday found. "This study shows that even...arlier in the course of treatment," said Dr. Bayar...erican Society of Oncology (ASCO) which brought to...
...JAMA, has identified novel genetic mutations linke... that these mutations are due to both independent ...as been released early to coincide with its presen...is the second most common cause of cancer death wo...
...sburgh Medical Center (UPMC) study presented at th...al Oncology (ASCO) in Chicago and published as Abs...ted for follicular lymphoma, a slow-growing type o...to the treatment and since only a short-course of ...
...nounced follow-up data from a Phase 2 clinical tri...ch was conducted by the Johns Hopkins Sidney Kimme...ith operable pancreatic cancer who received GVAX a... to be 26.8 months, a result which compares favora...
...end, even if it is all subtle, as in Canada appare...e hard to pin down is more dangerous to mental hea...dy of 180 Korean immigrants living in Canada. ...lead author Samuel Noh, professor of psychiatry at...
...g of SNM, the world's largest society for molecula...man researchers stated that early metabolic imagin...ely identifies patients responding to chemotherapy...the treatment of common solid tumors," said Ken He...
Other Medicine News:Health News:Researchers Identify Genetic Mutations for Hereditary Diffuse Gastric Cancer 2Health News:Researchers Identify Genetic Mutations for Hereditary Diffuse Gastric Cancer 3Health News:Lymphoma Patients Maybe Helped by Adding Radioimmunotherapy to Chemo 2Health News:Cell Genesys Reports Additional Data From Phase 2 Clinical Trial of GVAX Immunotherapy for Pancreatic Cancer 2Health News:Cell Genesys Reports Additional Data From Phase 2 Clinical Trial of GVAX Immunotherapy for Pancreatic Cancer 3Health News:Cell Genesys Reports Additional Data From Phase 2 Clinical Trial of GVAX Immunotherapy for Pancreatic Cancer 4Health News:Koreans in Canada Feel Put Down by Subtle Racism 2Health News:Esophageal Cancer Patients' Positive Responses to Chemotherapy Accurately Identified by PET 2
(Date:12/1/2009)...swire/ -- CCS Medical, Inc. a leading direct-to-co...ed that it has received approval from the United S...he "Court") for its bidding procedures in connecti...tially all of its assets. ,, Pursuant to an Ord...ding procedures for the sale of substantially all ...
(Date:12/1/2009)...rstCall/ -- CryoLife, Inc. ( CRY) , an implantabl...sue processing company, announced its initial fina... total revenues for the full year of 2010 to be be...ludes between $1.5 million and $2.5 million relate...se in connection with the development of BioFoam. ...
(Date:12/1/2009)...RNewswire/ -- Siemens Hearing Instruments, Inc., ...nufacturer of hearing instruments, announced its t... Sound Beginnings program. The alliance will be ef...he renewed partnership, Siemens is expanding the p...struments to both children and young adults, age 2...
Breaking Medicine Technology:CCS Medical Wins Approval from Bankruptcy Court for Its Chapter 11 Asset Sale Bidding Procedures 2CryoLife Provides Initial 2010 Financial Guidance 2CryoLife Provides Initial 2010 Financial Guidance 3CryoLife Provides Initial 2010 Financial Guidance 4CryoLife Provides Initial 2010 Financial Guidance 5Siemens Hearing Instruments Renews Quota Partnership to Give the Gift of Hearing to Children and Young Adults in Need 2Siemens Hearing Instruments Renews Quota Partnership to Give the Gift of Hearing to Children and Young Adults in Need 3Anxious Kids at Risk for Obesity in Adulthood 57251 1Anxious Kids at Risk for Obesity in Adulthood 57251 2Young Adults with Cancer Focus of Program Developed by Providence Saint Joseph Medical Center and Childrens Hospital Los Angeles 57247 1Young Adults with Cancer Focus of Program Developed by Providence Saint Joseph Medical Center and Childrens Hospital Los Angeles 57247 2Young Adults with Cancer Focus of Program Developed by Providence Saint Joseph Medical Center and Childrens Hospital Los Angeles 57247 3Insurance and HMO Industries Spend Nearly 24700 000 Per Day to Kill Health Care Reform Measures 57243 1Insurance and HMO Industries Spend Nearly 24700 000 Per Day to Kill Health Care Reform Measures 57243 2
...vember 21 , - Not for UK Journalists , ...r Human Use (CHMP) today,announced its positive re...cept) as a treatment for children aged 8 years and.... If approved by the European,Commission, followin...me the,first biologic treatment indicated for seve...
...ADELPHIA, Nov. 20 GlaxoSmithKline (NYSE: GSK ) t...g Administration (FDA) granted accelerated approva...of thrombocytopenia in patients with chronic immun...have had an insufficient response to corticosteroi...s a significant milestone for PROMACTA and the ITP...
Other Medicine Technology:CHMP Recommends Approval of New Indication for Enbrel(R) as Treatment for Severe Psoriasis in Paediatric Patients 2CHMP Recommends Approval of New Indication for Enbrel(R) as Treatment for Severe Psoriasis in Paediatric Patients 3CHMP Recommends Approval of New Indication for Enbrel(R) as Treatment for Severe Psoriasis in Paediatric Patients 4CHMP Recommends Approval of New Indication for Enbrel(R) as Treatment for Severe Psoriasis in Paediatric Patients 5FDA Approves Promacta(R) (Eltrombopag), the First Oral Medication to Increase Platelet Production for People With Serious Blood Disorder 2FDA Approves Promacta(R) (Eltrombopag), the First Oral Medication to Increase Platelet Production for People With Serious Blood Disorder 3FDA Approves Promacta(R) (Eltrombopag), the First Oral Medication to Increase Platelet Production for People With Serious Blood Disorder 4FDA Approves Promacta(R) (Eltrombopag), the First Oral Medication to Increase Platelet Production for People With Serious Blood Disorder 5FDA Approves Promacta(R) (Eltrombopag), the First Oral Medication to Increase Platelet Production for People With Serious Blood Disorder 6FDA Approves Promacta(R) (Eltrombopag), the First Oral Medication to Increase Platelet Production for People With Serious Blood Disorder 7FDA Approves Promacta(R) (Eltrombopag), the First Oral Medication to Increase Platelet Production for People With Serious Blood Disorder 8
Lacrimal Cannula, Curved - Open End.
PremierEdge™ Implant Knives
Universal I/A handpiece - Titanium (Binkhorst Tip)
Universal I/A handpiece - Titanium (Curved Tip, Size: 16g Outer Cannula)
Medicine Products: